Skip to content

AEON Biopharma, Inc.

AEON· NYSECore metricsCIK 1837607

Pharmaceutical preparations553 peers

Last sale
Nov 12, 2026 · -9.55%
Market cap
$8.08M
49.88M shares
Filings
367
—
—
—
-$1.16M
Q2 2026N/M FY25 yoy
-$5.92M
Q2 2026N/M FY25 yoy
-$17.31M
FY 2025derivedN/M FY25 yoy
-$0.02
Q2 2026N/M FY25 yoy
$3.43M
Q2 2026+23,023.1% FY25 yoy
$8.08M
—
—
—
-214.36%
—

FY2025 figures · derived

Price

$0.161982.21%$0.7481past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$4.09MFY 2025
$34.75M0FY 2022FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$4,094,000reported
FY 20242024-12-31$14,181,000reported
FY 20222022-12-31$34,754,000reported

Pharmaceutical preparations

AEON Biopharma, Inc. is the 432nd largest of the 554 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

AEON Biopharma, Inc. · CIK 1837607 · Engraved from SEC EDGAR